<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32927676</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1305</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom10091305</ELocationID><Abstract><AbstractText>Many devastating neurodegenerative diseases are driven by the misfolding of normal proteins into a pathogenic abnormal conformation. Examples of such protein misfolding diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and prion diseases. The misfolded proteins involved in these diseases form self-templating oligomeric assemblies that recruit further correctly folded protein and induce their conversion. Over time, this leads to the formation of high molecular and mostly fibrillar aggregates that are increasingly inefficient at converting normal protein. Evidence from a multitude of in vitro models suggests that fibrils are fragmented to form new seeds, which can convert further normal protein and also spread to neighboring cells as observed in vivo. While fragmentation and seed generation were suggested as crucial steps in aggregate formation decades ago, the biological pathways involved remain largely unknown. Here, we show that mechanisms of aggregate clearance-namely the mammalian Hsp70-Hsp40-Hsp110 tri-chaperone system, macro-autophagy, and the proteasome system-may not only be protective, but also play a role in fragmentation. We further review the challenges that exist in determining the precise contribution of these mechanisms to protein misfolding diseases and suggest future directions to resolve these issues.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marrero-Winkens</LastName><ForeName>Crist&#xf3;bal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Comparative Biology &amp; Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Calgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sankaran</LastName><ForeName>Charu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Comparative Biology &amp; Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Calgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Science, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;tzl</LastName><ForeName>Hermann M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-4972-8740</Identifier><AffiliationInfo><Affiliation>Department of Comparative Biology &amp; Experimental Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Calgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G2019000542</GrantID><Agency>Alberta Innovates</Agency><Country>International</Country></Grant><Grant><GrantID>201600010</GrantID><Agency>Alberta Innovates</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494647">DNAJB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050957">HSP110 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050956">HSP40 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018840">HSP70 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C097205">HSPH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072002">Prion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050957" MajorTopicYN="N">HSP110 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050956" MajorTopicYN="N">HSP40 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018840" MajorTopicYN="N">HSP70 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072002" MajorTopicYN="N">Prion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Hsp110</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyloid</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">disaggregation</Keyword><Keyword MajorTopicYN="N">fragmentation</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">prion diseases</Keyword><Keyword MajorTopicYN="N">protein misfolding</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>15</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32927676</ArticleId><ArticleId IdType="pmc">PMC7563560</ArticleId><ArticleId IdType="doi">10.3390/biom10091305</ArticleId><ArticleId IdType="pii">biom10091305</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dobson C.M. Protein-misfolding diseases: Getting out of shape. Nature. 2002;418:729&#x2013;730. doi: 10.1038/418729a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/418729a</ArticleId><ArticleId IdType="pubmed">12181546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson C.M. Protein folding and misfolding. Nature. 2003;426:884&#x2013;890. doi: 10.1038/nature02261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02261</ArticleId><ArticleId IdType="pubmed">14685248</ArticleId></ArticleIdList></Reference><Reference><Citation>Gooch C.L., Pracht E., Borenstein A.R. The burden of neurological disease in the United States: A summary report and call to action. Ann. Neurol. 2017;81:479&#x2013;484. doi: 10.1002/ana.24897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24897</ArticleId><ArticleId IdType="pubmed">28198092</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136&#x2013;144. doi: 10.1126/science.6801762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6801762</ArticleId><ArticleId IdType="pubmed">6801762</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA. 1998;95:13363&#x2013;13383. doi: 10.1073/pnas.95.23.13363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13363</ArticleId><ArticleId IdType="pmc">PMC33918</ArticleId><ArticleId IdType="pubmed">9811807</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith J.S. Nature of the scrapie agent: Self-replication and scrapie. Nature. 1967;215:1043&#x2013;1044. doi: 10.1038/2151043a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/2151043a0</ArticleId><ArticleId IdType="pubmed">4964084</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Diamond M.I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 2010;11:155&#x2013;159. doi: 10.1038/nrn2786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2786</ArticleId><ArticleId IdType="pmc">PMC3648341</ArticleId><ArticleId IdType="pubmed">20029438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z., Brandner S. Invited review: The role of prion-like mechanisms in neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2020 doi: 10.1111/nan.12592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12592</ArticleId><ArticleId IdType="pmc">PMC7687189</ArticleId><ArticleId IdType="pubmed">31868945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett J.T., Lansbury P.T. Seeding &#x201c;one-dimensional crystallization&#x201d; of amyloid: A pathogenic mechanism in Alzheimer&#x2019;s disease and scrapie? Cell. 1993;73:1055&#x2013;1058. doi: 10.1016/0092-8674(93)90635-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90635-4</ArticleId><ArticleId IdType="pubmed">8513491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiei S.S., Guerrero-Mu&#xf1;oz M.J., Castillo-Carranza D.L. Tau oligomers: Cytotoxicity, propagation, and mitochondrial damage. Front. Aging Neurosci. 2017;9 doi: 10.3389/fnagi.2017.00083.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00083</ArticleId><ArticleId IdType="pmc">PMC5378766</ArticleId><ArticleId IdType="pubmed">28420982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes D., Halliday M. What is our current understanding of PrPSc-associated neurotoxicity and its molecular underpinnings? Pathogens. 2017;6:63. doi: 10.3390/pathogens6040063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens6040063</ArticleId><ArticleId IdType="pmc">PMC5750587</ArticleId><ArticleId IdType="pubmed">29194372</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss A.B., Arain H.A., Stecker M.M., Siegart N.M., Kasselman L.J. Amyloid toxicity in Alzheimer&#x2019;s disease. Rev. Neurosci. 2018;29:613&#x2013;627. doi: 10.1515/revneuro-2017-0063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0063</ArticleId><ArticleId IdType="pubmed">29447116</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam P., Bousset L., Melki R., Otzen D.E. &#x3b1;-synuclein oligomers and fibrils: A spectrum of species, a spectrum of toxicities. J. Neurochem. 2019;150:522&#x2013;534. doi: 10.1111/jnc.14808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14808</ArticleId><ArticleId IdType="pubmed">31254394</ArticleId></ArticleIdList></Reference><Reference><Citation>Eigen M. Prionics or the kinetic basis of prion diseases. Biophys. Chem. 1996;63:A1&#x2013;A18. doi: 10.1016/S0301-4622(96)02250-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-4622(96)02250-8</ArticleId><ArticleId IdType="pubmed">8981746</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer&#x2019;s disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 1997;66:385&#x2013;407. doi: 10.1146/annurev.biochem.66.1.385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.66.1.385</ArticleId><ArticleId IdType="pubmed">9242912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandel J.-P., Culeux A., Grznarova K., Levavasseur E., Lamy P., Privat N., Welaratne A., Denouel A., Laplanche J.-L., Haik S. Amplification techniques and diagnosis of prion diseases. Rev. Neurol. 2019;175:458&#x2013;463. doi: 10.1016/j.neurol.2019.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2019.06.002</ArticleId><ArticleId IdType="pubmed">31296398</ArticleId></ArticleIdList></Reference><Reference><Citation>Paciotti S., Bellomo G., Gatticchi L., Parnetti L. Are we ready for detecting &#x3b1;-synuclein prone to aggregation in patients? The case of &#x201c;protein-misfolding cyclic amplification&#x201d; and &#x201c;real-time quaking-induced conversion&#x201d; as diagnostic tools. Front. Neurol. 2018;9:415. doi: 10.3389/fneur.2018.00415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00415</ArticleId><ArticleId IdType="pmc">PMC5997809</ArticleId><ArticleId IdType="pubmed">29928254</ArticleId></ArticleIdList></Reference><Reference><Citation>Do Carmo Ferreira N., Caughey B. Cell-free prion protein conversion assays in screening for anti-prion drug candidates. Curr. Opin. Pharm. 2019;44:1&#x2013;7. doi: 10.1016/j.coph.2018.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.10.001</ArticleId><ArticleId IdType="pubmed">30412823</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A.J.E. RT-QuIC: A new test for sporadic CJD. Pract. Neurol. 2019;19:49&#x2013;55. doi: 10.1136/practneurol-2018-001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2018-001935</ArticleId><ArticleId IdType="pmc">PMC6580883</ArticleId><ArticleId IdType="pubmed">30282760</ArticleId></ArticleIdList></Reference><Reference><Citation>Saborio G.P., Permanne B., Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810&#x2013;813. doi: 10.1038/35081095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35081095</ArticleId><ArticleId IdType="pubmed">11459061</ArticleId></ArticleIdList></Reference><Reference><Citation>Castilla J., Sa&#xe1; P., Hetz C., Soto C. In vitro generation of infectious scrapie prions. Cell. 2005;121:195&#x2013;206. doi: 10.1016/j.cell.2005.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.02.011</ArticleId><ArticleId IdType="pubmed">15851027</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Anderes L., Suardi S., Cardone F., Castilla J., Frossard M.-J., Peano S., Saa P., Limido L., Carbonatto M., et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett. 2005;579:638&#x2013;642. doi: 10.1016/j.febslet.2004.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.12.035</ArticleId><ArticleId IdType="pubmed">15670821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocisko D.A., Come J.H., Priola S.A., Chesebro B., Raymond G.J., Lansbury P.T., Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 1994;370:471&#x2013;474. doi: 10.1038/370471a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/370471a0</ArticleId><ArticleId IdType="pubmed">7913989</ArticleId></ArticleIdList></Reference><Reference><Citation>Atarashi R., Wilham J.M., Christensen L., Hughson A.G., Moore R.A., Johnson L.M., Onwubiko H.A., Priola S.A., Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods. 2008;5:211&#x2013;212. doi: 10.1038/nmeth0308-211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0308-211</ArticleId><ArticleId IdType="pubmed">18309304</ArticleId></ArticleIdList></Reference><Reference><Citation>Orru C.D., Wilham J.M., Hughson A.G., Raymond L.D., McNally K.L., Bossers A., Ligios C., Caughey B. Human variant Creutzfeldt-Jakob disease and sheep scrapie PrPres detection using seeded conversion of recombinant prion protein. Protein Eng. Des. Sel. 2009;22:515&#x2013;521. doi: 10.1093/protein/gzp031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/gzp031</ArticleId><ArticleId IdType="pmc">PMC2719501</ArticleId><ArticleId IdType="pubmed">19570812</ArticleId></ArticleIdList></Reference><Reference><Citation>Atarashi R., Satoh K., Sano K., Fuse T., Yamaguchi N., Ishibashi D., Matsubara T., Nakagaki T., Yamanaka H., Shirabe S., et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 2011;17:175&#x2013;178. doi: 10.1038/nm.2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2294</ArticleId><ArticleId IdType="pubmed">21278748</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz M., Cramm M., Llorens F., M&#xfc;ller-Cramm D., Collins S., Atarashi R., Satoh K., Orr&#xf9; C.D., Groveman B.R., Zafar S., et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat. Protoc. 2016;11:2233&#x2013;2242. doi: 10.1038/nprot.2016.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2016.120</ArticleId><ArticleId IdType="pubmed">27735933</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa&#xe1; P., Castilla J., Soto C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 2006;281:35245&#x2013;35252. doi: 10.1074/jbc.M603964200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M603964200</ArticleId><ArticleId IdType="pubmed">16982620</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvadores N., Shahnawaz M., Scarpini E., Tagliavini F., Soto C. Detection of misfolded A&#x3b2; oligomers for sensitive biochemical diagnosis of Alzheimer&#x2019;s disease. Cell Rep. 2014;7:261&#x2013;268. doi: 10.1016/j.celrep.2014.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.031</ArticleId><ArticleId IdType="pubmed">24656814</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadis A. Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim. Biophys. Acta Mol. Basis Dis. 2005;1739:91&#x2013;103. doi: 10.1016/j.bbadis.2004.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2004.08.010</ArticleId><ArticleId IdType="pubmed">15615629</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer V., Dinkel P.D., Rickman Hager E., Margittai M. Amplification of Tau fibrils from minute quantities of seeds. Biochemistry. 2014;53:5804&#x2013;5809. doi: 10.1021/bi501050g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi501050g</ArticleId><ArticleId IdType="pmc">PMC4165214</ArticleId><ArticleId IdType="pubmed">25153692</ArticleId></ArticleIdList></Reference><Reference><Citation>Saijo E., Ghetti B., Zanusso G., Oblak A., Furman J.L., Diamond M.I., Kraus A., Caughey B. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid. Acta Neuropathol. 2017;133:751&#x2013;765. doi: 10.1007/s00401-017-1692-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1692-z</ArticleId><ArticleId IdType="pubmed">28293793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraus A., Saijo E., Metrick M.A., Newell K., Sigurdson C.J., Zanusso G., Ghetti B., Caughey B. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease. Acta Neuropathol. 2019;137:585&#x2013;598. doi: 10.1007/s00401-018-1947-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1947-3</ArticleId><ArticleId IdType="pmc">PMC6426988</ArticleId><ArticleId IdType="pubmed">30570675</ArticleId></ArticleIdList></Reference><Reference><Citation>Metrick M.A., Do Carmo Ferreira N., Saijo E., Kraus A., Newell K., Zanusso G., Vendruscolo M., Ghetti B., Caughey B. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases. Acta Neuropathol. Commun. 2020;8:22. doi: 10.1186/s40478-020-0887-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0887-z</ArticleId><ArticleId IdType="pmc">PMC7036215</ArticleId><ArticleId IdType="pubmed">32087764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran G., Udgaonkar J.B. Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau. J. Mol. Biol. 2012;421:296&#x2013;314. doi: 10.1016/j.jmb.2012.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.01.007</ArticleId><ArticleId IdType="pubmed">22281439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairfoul G., McGuire L.I., Pal S., Ironside J.W., Neumann J., Christie S., Joachim C., Esiri M., Evetts S.G., Rolinski M., et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 2016;3:812&#x2013;818. doi: 10.1002/acn3.338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.338</ArticleId><ArticleId IdType="pmc">PMC5048391</ArticleId><ArticleId IdType="pubmed">27752516</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahnawaz M., Tokuda T., Waragai M., Mendez N., Ishii R., Trenkwalder C., Mollenhauer B., Soto C. Development of a biochemical diagnosis of Parkinson disease by detection of &#x3b1;-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 2017;74:163&#x2013;172. doi: 10.1001/jamaneurol.2016.4547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.4547</ArticleId><ArticleId IdType="pubmed">27918765</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman B.R., Orr&#xf9; C.D., Hughson A.G., Raymond L.D., Zanusso G., Ghetti B., Campbell K.J., Safar J., Galasko D., Caughey B. Rapid and ultra-sensitive quantitation of disease-associated &#x3b1;-synuclein seeds in brain and cerebrospinal fluid by &#x3b1;Syn RT-QuIC. Acta Neuropathol. Commun. 2018;6:7. doi: 10.1186/s40478-018-0508-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0508-2</ArticleId><ArticleId IdType="pmc">PMC5806364</ArticleId><ArticleId IdType="pubmed">29422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahnawaz M., Mukherjee A., Pritzkow S., Mendez N., Rabadia P., Liu X., Hu B., Schmeichel A., Singer W., Wu G., et al. Discriminating &#x3b1;-synuclein strains in Parkinson&#x2019;s disease and multiple system atrophy. Nature. 2020;578:273&#x2013;277. doi: 10.1038/s41586-020-1984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1984-7</ArticleId><ArticleId IdType="pmc">PMC7066875</ArticleId><ArticleId IdType="pubmed">32025029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B., Edskes H.K., Son M., Wu S., Niznikiewicz M. How do yeast cells contend with prions? Int. J. Mol. Sci. 2020;21:4742. doi: 10.3390/ijms21134742.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21134742</ArticleId><ArticleId IdType="pmc">PMC7369894</ArticleId><ArticleId IdType="pubmed">32635197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B. Anti-prion systems in yeast. J. Biol. Chem. 2019;294:1729&#x2013;1738. doi: 10.1074/jbc.TM118.004168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.004168</ArticleId><ArticleId IdType="pmc">PMC6364766</ArticleId><ArticleId IdType="pubmed">30710020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernova T.A., Wilkinson K.D., Chernoff Y.O. Prions, chaperones, and proteostasis in yeast. Cold Spring Harb. Perspect. Biol. 2017;9 doi: 10.1101/cshperspect.a023663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a023663</ArticleId><ArticleId IdType="pmc">PMC5287078</ArticleId><ArticleId IdType="pubmed">27815300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B., Shewmaker F.P., Bateman D.A., Edskes H.K., Gorkovskiy A., Dayani Y., Bezsonov E.E. Yeast prions: Structure, biology, and prion-handling systems. Microbiol. Mol. Biol. Rev. 2015;79:1&#x2013;17. doi: 10.1128/MMBR.00041-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00041-14</ArticleId><ArticleId IdType="pmc">PMC4402965</ArticleId><ArticleId IdType="pubmed">25631286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B. [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science. 1994;264:566&#x2013;569. doi: 10.1126/science.7909170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7909170</ArticleId><ArticleId IdType="pubmed">7909170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., Liebman S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+] Science. 1995;268:880&#x2013;884. doi: 10.1126/science.7754373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7754373</ArticleId><ArticleId IdType="pubmed">7754373</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff Y.O., Derkach I.L., Inge-Vechtomov S.G. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet. 1993;24:268&#x2013;270. doi: 10.1007/BF00351802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00351802</ArticleId><ArticleId IdType="pubmed">8221937</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama H., Edskes H.K., Wickner R.B. [URE3] prion propagation in Saccharomyces cerevisiae: Requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol. Cell. Biol. 2000;20:8916&#x2013;8922. doi: 10.1128/MCB.20.23.8916-8922.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.23.8916-8922.2000</ArticleId><ArticleId IdType="pmc">PMC86546</ArticleId><ArticleId IdType="pubmed">11073991</ArticleId></ArticleIdList></Reference><Reference><Citation>Paushkin S.V., Kushnirov V.V., Smirnov V.N., Ter-Avanesyan M.D. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 1996;15:3127&#x2013;3134. doi: 10.1002/j.1460-2075.1996.tb00675.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb00675.x</ArticleId><ArticleId IdType="pmc">PMC450255</ArticleId><ArticleId IdType="pubmed">8670813</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J., Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science. 2004;304:1793&#x2013;1797. doi: 10.1126/science.1098007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1098007</ArticleId><ArticleId IdType="pubmed">15155912</ArticleId></ArticleIdList></Reference><Reference><Citation>Glover J.R., Lindquist S. Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins. Cell. 1998;94:73&#x2013;82. doi: 10.1016/S0092-8674(00)81223-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81223-4</ArticleId><ArticleId IdType="pubmed">9674429</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer C., Kryndushkin D., Suhre M.H., Kremmer E., Hofmann A., Pfeifer A., Scheibel T., Wickner R.B., Sch&#xe4;tzl H.M., Vorberg I. The yeast Sup35NM domain propagates as a prion in mammalian cells. Proc. Natl. Acad. Sci. USA. 2009;106:462&#x2013;467. doi: 10.1073/pnas.0811571106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811571106</ArticleId><ArticleId IdType="pmc">PMC2626725</ArticleId><ArticleId IdType="pubmed">19114662</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S.I.A., Linse S., Luheshi L.M., Hellstrand E., White D.A., Rajah L., Otzen D.E., Vendruscolo M., Dobson C.M., Knowles T.P.J. Proliferation of amyloid-&#x3b2;42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. USA. 2013;110:9758&#x2013;9763. doi: 10.1073/pnas.1218402110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218402110</ArticleId><ArticleId IdType="pmc">PMC3683769</ArticleId><ArticleId IdType="pubmed">23703910</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheidt T., &#x141;api&#x144;ska U., Kumita J.R., Whiten D.R., Klenerman D., Wilson M.R., Cohen S.I.A., Linse S., Vendruscolo M., Dobson C.M., et al. Secondary nucleation and elongation occur at different sites on Alzheimer&#x2019;s amyloid-&#x3b2; aggregates. Sci. Adv. 2019;5:eaau3112. doi: 10.1126/sciadv.aau3112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau3112</ArticleId><ArticleId IdType="pmc">PMC6469941</ArticleId><ArticleId IdType="pubmed">31001578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar R., Meisl G., Buell A.K., Young L., Kaminski C.F., Knowles T.P.J., Sparr E., Linse S. Secondary nucleation of monomers on fibril surface dominates &#x3b1;-synuclein aggregation and provides autocatalytic amyloid amplification. Q. Rev. Biophys. 2017;50:e6. doi: 10.1017/S0033583516000172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033583516000172</ArticleId><ArticleId IdType="pubmed">29233218</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisl G., Knowles T.P., Klenerman D. The molecular processes underpinning prion-like spreading and seed amplification in protein aggregation. Curr. Opin. Neurobiol. 2020;61:58&#x2013;64. doi: 10.1016/j.conb.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2020.01.010</ArticleId><ArticleId IdType="pubmed">32092527</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaips C.L., Jayaraj G.G., Hartl F.U. Pathways of cellular proteostasis in aging and disease. J. Cell Biol. 2018;217:51&#x2013;63. doi: 10.1083/jcb.201709072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709072</ArticleId><ArticleId IdType="pmc">PMC5748993</ArticleId><ArticleId IdType="pubmed">29127110</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;sl B., Grimminger V., Walter S. The molecular chaperone Hsp104&#x2014;A molecular machine for protein disaggregation. J. Struct. Biol. 2006;156:139&#x2013;148. doi: 10.1016/j.jsb.2006.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2006.02.004</ArticleId><ArticleId IdType="pubmed">16563798</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorter J. The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system. PLoS ONE. 2011;6:e26319. doi: 10.1371/journal.pone.0026319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026319</ArticleId><ArticleId IdType="pmc">PMC3194798</ArticleId><ArticleId IdType="pubmed">22022600</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampelt H., Kirstein-Miles J., Nillegoda N.B., Chi K., Scholz S.R., Morimoto R.I., Bukau B. Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J. 2012;31:4221&#x2013;4235. doi: 10.1038/emboj.2012.264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.264</ArticleId><ArticleId IdType="pmc">PMC3492728</ArticleId><ArticleId IdType="pubmed">22990239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Carroni M., Nussbaum-Krammer C., Mogk A., Nillegoda N.B., Szlachcic A., Guilbride D.L., Saibil H.R., Mayer M.P., Bukau B. Human Hsp70 disaggregase reverses Parkinson&#x2019;s-linked &#x3b1;-synuclein amyloid fibrils. Mol. Cell. 2015;59:781&#x2013;793. doi: 10.1016/j.molcel.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC5072489</ArticleId><ArticleId IdType="pubmed">26300264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachman E., Wentink A.S., Madiona K., Bousset L., Katsinelos T., Allinson K., Kampinga H., McEwan W.A., Jahn T.R., Melki R., et al. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species. J. Biol. Chem. 2020 doi: 10.1074/jbc.RA120.013478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.013478</ArticleId><ArticleId IdType="pmc">PMC7363153</ArticleId><ArticleId IdType="pubmed">32467226</ArticleId></ArticleIdList></Reference><Reference><Citation>Tittelmeier J., Sandhof C.A., Ries H.M., Druffel-Augustin S., Mogk A., Bukau B., Nussbaum-Krammer C. The HSP110/HSP70 disaggregation system generates spreading-competent toxic &#x3b1;-synuclein species. EMBO J. 2020 doi: 10.15252/embj.2019103954.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019103954</ArticleId><ArticleId IdType="pmc">PMC7327497</ArticleId><ArticleId IdType="pubmed">32449565</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherty K.M., DeLuca-Flaherty C., McKay D.B. Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein. Nature. 1990;346:623&#x2013;628. doi: 10.1038/346623a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/346623a0</ArticleId><ArticleId IdType="pubmed">2143562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Zhao X., Burkholder W.F., Gragerov A., Ogata C.M., Gottesman M.E., Hendrickson W.A. Structural analysis of substrate binding by the molecular chaperone DnaK. Science. 1996;272:1606&#x2013;1614. doi: 10.1126/science.272.5268.1606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.272.5268.1606</ArticleId><ArticleId IdType="pmc">PMC5629921</ArticleId><ArticleId IdType="pubmed">8658133</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo A., Langer T., Schr&#xf6;der H., Flanagan J., Bukau B., Hartl F.U. The ATP hydrolysis-dependent reaction cycle of the Escherichia coli Hsp70 system DnaK, DnaJ, and GrpE. Proc. Natl. Acad. Sci. USA. 1994;91:10345&#x2013;10349. doi: 10.1073/pnas.91.22.10345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.22.10345</ArticleId><ArticleId IdType="pmc">PMC45016</ArticleId><ArticleId IdType="pubmed">7937953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuravleva A., Clerico E.M., Gierasch L.M. An interdomain energetic tug-of-war creates the allosterically active state in Hsp70 molecular chaperones. Cell. 2012;151:1296&#x2013;1307. doi: 10.1016/j.cell.2012.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.002</ArticleId><ArticleId IdType="pmc">PMC3521165</ArticleId><ArticleId IdType="pubmed">23217711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nillegoda N.B., Kirstein J., Szlachcic A., Berynskyy M., Stank A., Stengel F., Arnsburg K., Gao X., Scior A., Aebersold R., et al. Crucial HSP70 co-chaperone complex unlocks metazoan protein disaggregation. Nature. 2015;524:247&#x2013;251. doi: 10.1038/nature14884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14884</ArticleId><ArticleId IdType="pmc">PMC4830470</ArticleId><ArticleId IdType="pubmed">26245380</ArticleId></ArticleIdList></Reference><Reference><Citation>Nillegoda N.B., Bukau B. Metazoan Hsp70-based protein disaggregases: Emergence and mechanisms. Front. Mol. Biosci. 2015;2 doi: 10.3389/fmolb.2015.00057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2015.00057</ArticleId><ArticleId IdType="pmc">PMC4598581</ArticleId><ArticleId IdType="pubmed">26501065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nillegoda N.B., Wentink A.S., Bukau B. Protein disaggregation in multicellular organisms. Trends Biochem. Sci. 2018;43:285&#x2013;300. doi: 10.1016/j.tibs.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2018.02.003</ArticleId><ArticleId IdType="pubmed">29501325</ArticleId></ArticleIdList></Reference><Reference><Citation>Hipp M.S., Park S.-H., Hartl F.U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 2014;24:506&#x2013;514. doi: 10.1016/j.tcb.2014.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2014.05.003</ArticleId><ArticleId IdType="pubmed">24946960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wacker J.L., Huang S.-Y., Steele A.D., Aron R., Lotz G.P., Nguyen Q., Giorgini F., Roberson E.D., Lindquist S., Masliah E., et al. Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington&#x2019;s disease. J. Neurosci. 2009;29:9104&#x2013;9114. doi: 10.1523/JNEUROSCI.2250-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2250-09.2009</ArticleId><ArticleId IdType="pmc">PMC2739279</ArticleId><ArticleId IdType="pubmed">19605647</ArticleId></ArticleIdList></Reference><Reference><Citation>Eroglu B., Moskophidis D., Mivechi N.F. Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta. Mol. Cell. Biol. 2010;30:4626&#x2013;4643. doi: 10.1128/MCB.01493-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01493-09</ArticleId><ArticleId IdType="pmc">PMC2950521</ArticleId><ArticleId IdType="pubmed">20679486</ArticleId></ArticleIdList></Reference><Reference><Citation>Mays C.E., Armijo E., Morales R., Kramm C., Flores A., Tiwari A., Bian J., Telling G.C., Pandita T.K., Hunt C.R., et al. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70) J. Biol. Chem. 2019;294:13619&#x2013;13628. doi: 10.1074/jbc.RA118.006186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006186</ArticleId><ArticleId IdType="pmc">PMC6746463</ArticleId><ArticleId IdType="pubmed">31320473</ArticleId></ArticleIdList></Reference><Reference><Citation>Klucken J., Shin Y., Masliah E., Hyman B.T., McLean P.J. Hsp70 reduces &#x3b1;-synuclein aggregation and toxicity. J. Biol. Chem. 2004;279:25497&#x2013;25502. doi: 10.1074/jbc.M400255200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400255200</ArticleId><ArticleId IdType="pubmed">15044495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamg&#xfc;ney G., Giles K., Glidden D.V., Lessard P., Wille H., Tremblay P., Groth D.F., Yehiely F., Korth C., Moore R.C., et al. Genes contributing to prion pathogenesis. J. Gen. Virol. 2008;89:1777&#x2013;1788. doi: 10.1099/vir.0.2008/001255-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001255-0</ArticleId><ArticleId IdType="pmc">PMC2828448</ArticleId><ArticleId IdType="pubmed">18559949</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy M., Fenton W.A., Li D., Furtak K., Horwich A.L. Extended survival of misfolded G85R SOD1-linked ALS mice by transgenic expression of chaperone Hsp110. Proc. Natl. Acad. Sci. USA. 2016;113:5424&#x2013;5428. doi: 10.1073/pnas.1604885113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604885113</ArticleId><ArticleId IdType="pmc">PMC4868459</ArticleId><ArticleId IdType="pubmed">27114530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi Y.V., Gorenberg E.L., Nagy M., Thrasher D., Fenton W.A., Volpicelli-Daley L., Horwich A.L., Chandra S.S. Hsp110 mitigates &#x3b1;-synuclein pathology in vivo. Proc. Natl. Acad. Sci. USA. 2019;116:24310&#x2013;24316. doi: 10.1073/pnas.1903268116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1903268116</ArticleId><ArticleId IdType="pmc">PMC6883785</ArticleId><ArticleId IdType="pubmed">31685606</ArticleId></ArticleIdList></Reference><Reference><Citation>Parzych K.R., Klionsky D.J. An overview of autophagy: Morphology, mechanism, and regulation. Antioxid. Redox Signal. 2014;20:460&#x2013;473. doi: 10.1089/ars.2013.5371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5371</ArticleId><ArticleId IdType="pmc">PMC3894687</ArticleId><ArticleId IdType="pubmed">23725295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessvik N.P., Llorente A. Current knowledge on exosome biogenesis and release. Cell. Mol. Life Sci. 2018;75:193&#x2013;208. doi: 10.1007/s00018-017-2595-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2595-9</ArticleId><ArticleId IdType="pmc">PMC5756260</ArticleId><ArticleId IdType="pubmed">28733901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua C.E.L., Gan B.Q., Tang B.L. Involvement of members of the Rab family and related small GTPases in autophagosome formation and maturation. Cell. Mol. Life Sci. 2011;68:3349&#x2013;3358. doi: 10.1007/s00018-011-0748-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-011-0748-9</ArticleId><ArticleId IdType="pubmed">21687989</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B., Kroemer G. Biological functions of autophagy genes: A disease perspective. Cell. 2019;176:11&#x2013;42. doi: 10.1016/j.cell.2018.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.048</ArticleId><ArticleId IdType="pmc">PMC6347410</ArticleId><ArticleId IdType="pubmed">30633901</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J. Autophagy participates in, well, just about everything. Cell Death Differ. 2020;27:831&#x2013;832. doi: 10.1038/s41418-020-0511-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0511-6</ArticleId><ArticleId IdType="pmc">PMC7206120</ArticleId><ArticleId IdType="pubmed">32034315</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelaziz D.H., Abdulrahman B.A., Gilch S., Schatzl H.M. Autophagy pathways in the treatment of prion diseases. Curr. Opin. Pharmacol. 2019;44:46&#x2013;52. doi: 10.1016/j.coph.2019.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2019.04.013</ArticleId><ArticleId IdType="pmc">PMC6610235</ArticleId><ArticleId IdType="pubmed">31096117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertmer A., Gilch S., Yun S.-W., Flechsig E., Klebl B., Stein-Gerlach M., Klein M.A., Schatzl H.M. The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells. J. Biol. Chem. 2004;279:41918&#x2013;41927. doi: 10.1074/jbc.M405652200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M405652200</ArticleId><ArticleId IdType="pubmed">15247213</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguib Y., Heiseke A., Gilch S., Riemer C., Baier M., Ertmer A., Sch&#xe4;tzl H.M. Autophagy induction by trehalose counter-acts cellular prion-infection. Autophagy. 2009;5:361&#x2013;369. doi: 10.4161/auto.5.3.7662.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5.3.7662</ArticleId><ArticleId IdType="pubmed">19182537</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiseke A., Aguib Y., Riemer C., Baier M., Sch&#xe4;tzl H.M. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J. Neurochem. 2009;109:25&#x2013;34. doi: 10.1111/j.1471-4159.2009.05906.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.05906.x</ArticleId><ArticleId IdType="pubmed">19183256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagaki T., Satoh K., Ishibashi D., Fuse T., Sano K., Kamatari Y.O., Kuwata K., Shigematsu K., Iwamaru Y., Takenouchi T., et al. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. Autophagy. 2013;9:1386&#x2013;1394. doi: 10.4161/auto.25381.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25381</ArticleId><ArticleId IdType="pubmed">23800841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi D., Homma T., Nakagaki T., Fuse T., Sano K., Takatsuki H., Atarashi R., Nishida N. Strain-dependent effect of macroautophagy on abnormally folded prion protein degradation in infected neuronal cells. PLoS ONE. 2015;10:e0137958. doi: 10.1371/journal.pone.0137958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137958</ArticleId><ArticleId IdType="pmc">PMC4569470</ArticleId><ArticleId IdType="pubmed">26368533</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman B.A., Abdelaziz D., Thapa S., Lu L., Jain S., Gilch S., Proniuk S., Zukiwski A., Schatzl H.M. The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions. Sci. Rep. 2017;7:17565. doi: 10.1038/s41598-017-17770-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17770-8</ArticleId><ArticleId IdType="pmc">PMC5730578</ArticleId><ArticleId IdType="pubmed">29242534</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S.-W., Ertmer A., Flechsig E., Gilch S., Riederer P., Gerlach M., Sch&#xe4;tzl H.M., Klein M.A. The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery. J. Neurovirol. 2007;13:328&#x2013;337. doi: 10.1080/13550280701361516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280701361516</ArticleId><ArticleId IdType="pubmed">17849316</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C.J., Qin K., Cook J., Solanki A., Mastrianni J.A. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Straussler-Scheinker disease. J. Neurosci. 2012;32:12396&#x2013;12405. doi: 10.1523/JNEUROSCI.6189-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6189-11.2012</ArticleId><ArticleId IdType="pmc">PMC3752082</ArticleId><ArticleId IdType="pubmed">22956830</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman B.A., Tahir W., Doh-Ura K., Gilch S., Schatzl H.M. Combining autophagy stimulators and cellulose ethers for therapy against prion disease. Prion. 2019;13:185&#x2013;196. doi: 10.1080/19336896.2019.1670928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2019.1670928</ArticleId><ArticleId IdType="pmc">PMC6779372</ArticleId><ArticleId IdType="pubmed">31578923</ArticleId></ArticleIdList></Reference><Reference><Citation>Arotcarena M.-L., Teil M., Dehay B. Autophagy in synucleinopathy: The overwhelmed and defective machinery. Cells. 2019;8:565. doi: 10.3390/cells8060565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8060565</ArticleId><ArticleId IdType="pmc">PMC6627933</ArticleId><ArticleId IdType="pubmed">31181865</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li L. Targeting autophagy for the treatment of Alzheimer&#x2019;s disease: Challenges and opportunities. Front. Mol. Neurosci. 2019;12 doi: 10.3389/fnmol.2019.00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00203</ArticleId><ArticleId IdType="pmc">PMC6713911</ArticleId><ArticleId IdType="pubmed">31507373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Shin J.H., Lee J.E., Choi E.-J. Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2015;1852:2517&#x2013;2524. doi: 10.1016/j.bbadis.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.08.005</ArticleId><ArticleId IdType="pubmed">26264610</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Majumder S., Richardson A., Strong R., Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: Effects on cognitive impairments. J. Biol. Chem. 2010;285:13107&#x2013;13120. doi: 10.1074/jbc.M110.100420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.100420</ArticleId><ArticleId IdType="pmc">PMC2857107</ArticleId><ArticleId IdType="pubmed">20178983</ArticleId></ArticleIdList></Reference><Reference><Citation>Spilman P., Podlutskaya N., Hart M.J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer&#x2019;s disease. PLoS ONE. 2010;5:e9979. doi: 10.1371/journal.pone.0009979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009979</ArticleId><ArticleId IdType="pmc">PMC2848616</ArticleId><ArticleId IdType="pubmed">20376313</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O&#x2019;Kane C.J., et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2006;15:433&#x2013;442. doi: 10.1093/hmg/ddi458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi458</ArticleId><ArticleId IdType="pubmed">16368705</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer V., Lavenir I., Ozcelik S., Tolnay M., Winkler D.T., Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 2012;135:2169&#x2013;2177. doi: 10.1093/brain/aws143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws143</ArticleId><ArticleId IdType="pmc">PMC3381726</ArticleId><ArticleId IdType="pubmed">22689910</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A., Magr&#xec; A., Medina D.X., Wisely E.V., L&#xf3;pez-Aranda M.F., Silva A.J., Oddo S. mTOR regulates tau phosphorylation and degradation: Implications for Alzheimer&#x2019;s disease and other tauopathies. Aging Cell. 2013;12:370&#x2013;380. doi: 10.1111/acel.12057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12057</ArticleId><ArticleId IdType="pmc">PMC3655115</ArticleId><ArticleId IdType="pubmed">23425014</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb J.L., Ravikumar B., Atkins J., Skepper J.N., Rubinsztein D.C. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 2003;278:25009&#x2013;25013. doi: 10.1074/jbc.M300227200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M300227200</ArticleId><ArticleId IdType="pubmed">12719433</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 2007;282:5641&#x2013;5652. doi: 10.1074/jbc.M609532200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609532200</ArticleId><ArticleId IdType="pubmed">17182613</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer B., Potkar R., Trejo M., Rockenstein E., Patrick C., Gindi R., Adame A., Wyss-Coray T., Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson&#x2019;s and Lewy body diseases. J. Neurosci. 2009;29:13578&#x2013;13588. doi: 10.1523/JNEUROSCI.4390-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4390-09.2009</ArticleId><ArticleId IdType="pmc">PMC2812014</ArticleId><ArticleId IdType="pubmed">19864570</ArticleId></ArticleIdList></Reference><Reference><Citation>Malagelada C., Jin Z.H., Jackson-Lewis V., Przedborski S., Greene L.A. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson&#x2019;s disease. J. Neurosci. 2010;30:1166&#x2013;1175. doi: 10.1523/JNEUROSCI.3944-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3944-09.2010</ArticleId><ArticleId IdType="pmc">PMC2880868</ArticleId><ArticleId IdType="pubmed">20089925</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiseke A., Aguib Y., Schatzl H.M. Autophagy, prion infection and their mutual interactions. Curr. Issues Mol. Biol. 2010;12:87&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">19767652</ArticleId></ArticleIdList></Reference><Reference><Citation>Schatzl H.M. Cellular mechanisms of propagation and clearance. In: Zou W.-Q., Gambetti P., editors. Prions and Diseases: Volume 1, Physiology and Pathophysiology. Springer; New York, NY, USA: 2013. pp. 147&#x2013;160.</Citation></Reference><Reference><Citation>B&#xe9;ranger F., Mang&#xe9; A., Goud B., Lehmann S. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells. J. Biol. Chem. 2002;277:38972&#x2013;38977. doi: 10.1074/jbc.M205110200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M205110200</ArticleId><ArticleId IdType="pubmed">12163492</ArticleId></ArticleIdList></Reference><Reference><Citation>Marijanovic Z., Caputo A., Campana V., Zurzolo C. Identification of an Intracellular site of prion conversion. PLoS Pathog. 2009;5:e1000426. doi: 10.1371/journal.ppat.1000426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000426</ArticleId><ArticleId IdType="pmc">PMC2673690</ArticleId><ArticleId IdType="pubmed">19424437</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilch S., Bach C., Lutzny G., Vorberg I., Sch&#xe4;tzl H.M. Inhibition of cholesterol recycling impairs cellular PrPSc propagation. Cell Mol. Life Sci. 2009;66:3979&#x2013;3991. doi: 10.1007/s00018-009-0158-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-009-0158-4</ArticleId><ArticleId IdType="pmc">PMC2777232</ArticleId><ArticleId IdType="pubmed">19823766</ArticleId></ArticleIdList></Reference><Reference><Citation>Yim Y.-I., Park B.-C., Yadavalli R., Zhao X., Eisenberg E., Greene L.E. The multivesicular body is the major internal site of prion conversion. J. Cell Sci. 2015;128:1434&#x2013;1443. doi: 10.1242/jcs.165472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165472</ArticleId><ArticleId IdType="pmc">PMC4379730</ArticleId><ArticleId IdType="pubmed">25663703</ArticleId></ArticleIdList></Reference><Reference><Citation>Limanaqi F., Biagioni F., Gambardella S., Familiari P., Frati A., Fornai F. Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies. Int. J. Mol. Sci. 2020;21:3028. doi: 10.3390/ijms21083028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21083028</ArticleId><ArticleId IdType="pmc">PMC7215558</ArticleId><ArticleId IdType="pubmed">32344772</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman B.A., Abdelaziz D.H., Schatzl H.M. Autophagy regulates exosomal release of prions in neuronal cells. J. Biol. Chem. 2018;293:8956&#x2013;8968. doi: 10.1074/jbc.RA117.000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.000713</ArticleId><ArticleId IdType="pmc">PMC5995502</ArticleId><ArticleId IdType="pubmed">29700113</ArticleId></ArticleIdList></Reference><Reference><Citation>Danzer K.M., Kranich L.R., Ruf W.P., Cagsal-Getkin O., Winslow A.R., Zhu L., Vanderburg C.R., McLean P.J. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol. Neurodegener. 2012;7:42. doi: 10.1186/1750-1326-7-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-42</ArticleId><ArticleId IdType="pmc">PMC3483256</ArticleId><ArticleId IdType="pubmed">22920859</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.-J., Cho E.-D., Lee K.W., Kim J.-H., Cho S.-G., Lee S.-J. Autophagic failure promotes the exocytosis and intercellular transfer of &#x3b1;-synuclein. Exp. Mol. Med. 2013;45:e22. doi: 10.1038/emm.2013.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2013.45</ArticleId><ArticleId IdType="pmc">PMC3674407</ArticleId><ArticleId IdType="pubmed">23661100</ArticleId></ArticleIdList></Reference><Reference><Citation>Tixador P., Herzog L., Reine F., Jaumain E., Chapuis J., Le Dur A., Laude H., B&#xe9;ringue V. The Physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010;6 doi: 10.1371/journal.ppat.1000859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000859</ArticleId><ArticleId IdType="pmc">PMC2855332</ArticleId><ArticleId IdType="pubmed">20419156</ArticleId></ArticleIdList></Reference><Reference><Citation>Silveira J.R., Hughson A.G., Caughey B. Methods in Enzymology. Vol. 412. Academic Press; Cambridge, MA, USA: 2006. Fractionation of prion protein aggregates by asymmetrical flow field-flow fractionation; pp. 21&#x2013;33. Amyloid, Prions, and Other Protein Aggregates, Part B.</Citation><ArticleIdList><ArticleId IdType="pubmed">17046649</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C., Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818&#x2013;822. doi: 10.1126/science.aax3769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3769</ArticleId><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.117</ArticleId><ArticleId IdType="pmc">PMC4351408</ArticleId><ArticleId IdType="pubmed">25766616</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.M. Could a common mechanism of protein degradation impairment underlie many neurodegenerative diseases? J. Exp. Neurosci. 2018;12 doi: 10.1177/1179069518794675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179069518794675</ArticleId><ArticleId IdType="pmc">PMC6102758</ArticleId><ArticleId IdType="pubmed">30147359</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen M., Deriziotis P., Dimcheff D.E., Jackson G.S., Ovaa H., Naumann H., Clarke A.R., Van Leeuwen F.W.B., Men&#xe9;ndez-Benito V., Dantuma N.P., et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol. Cell. 2007;26:175&#x2013;188. doi: 10.1016/j.molcel.2007.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.04.001</ArticleId><ArticleId IdType="pubmed">17466621</ArticleId></ArticleIdList></Reference><Reference><Citation>Deriziotis P., Andr&#xe9; R., Smith D.M., Goold R., Kinghorn K.J., Kristiansen M., Nathan J.A., Rosenzweig R., Krutauz D., Glickman M.H., et al. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry. EMBO J. 2011;30:3065&#x2013;3077. doi: 10.1038/emboj.2011.224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.224</ArticleId><ArticleId IdType="pmc">PMC3160194</ArticleId><ArticleId IdType="pubmed">21743439</ArticleId></ArticleIdList></Reference><Reference><Citation>Keck S., Nitsch R., Grune T., Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer&#x2019;s disease. J. Neurochem. 2003;85:115&#x2013;122. doi: 10.1046/j.1471-4159.2003.01642.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01642.x</ArticleId><ArticleId IdType="pubmed">12641733</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaudeau T.A., Anderson R.T., Smith D.M. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers. Nat. Commun. 2018;9:1097. doi: 10.1038/s41467-018-03509-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03509-0</ArticleId><ArticleId IdType="pmc">PMC5854577</ArticleId><ArticleId IdType="pubmed">29545515</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinnon C., De Snoo M.L., Gondard E., Neudorfer C., Chau H., Ngana S.G., O&#x2019;Hara D.M., Brotchie J.M., Koprich J.B., Lozano A.M., et al. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by &#x3b1;-synuclein. Acta Neuropathol. Commun. 2020;8:17. doi: 10.1186/s40478-020-0894-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0894-0</ArticleId><ArticleId IdType="pmc">PMC7023783</ArticleId><ArticleId IdType="pubmed">32059750</ArticleId></ArticleIdList></Reference><Reference><Citation>Agholme L., Hallbeck M., Benedikz E., Marcusson J., K&#xe5;gedal K. Amyloid-&#x3b2; secretion, generation, and lysosomal sequestration in response to proteasome inhibition: Involvement of autophagy. J. Alzheimers Dis. 2012;31:343&#x2013;358. doi: 10.3233/JAD-2012-120001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-120001</ArticleId><ArticleId IdType="pubmed">22555375</ArticleId></ArticleIdList></Reference><Reference><Citation>Minoia M., Boncoraglio A., Vinet J., Morelli F.F., Brunsting J.F., Poletti A., Krom S., Reits E., Kampinga H.H., Carra S. BAG3 induces the sequestration of proteasomal clients into cytoplasmic puncta: Implications for a proteasome-to-autophagy switch. Autophagy. 2014;10:1603&#x2013;1621. doi: 10.4161/auto.29409.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.29409</ArticleId><ArticleId IdType="pmc">PMC4206538</ArticleId><ArticleId IdType="pubmed">25046115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama S., Sou Y., Uemura T., Kametaka S., Saito T., Ishimura R., Kouno T., Bedford L., Mayer R.J., Lee M.-S., et al. Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway. J. Biol. Chem. 2014;289:24944&#x2013;24955. doi: 10.1074/jbc.M114.580357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.580357</ArticleId><ArticleId IdType="pmc">PMC4155663</ArticleId><ArticleId IdType="pubmed">25049227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan D., Wang W., Zhuang J., Zhao Z. Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant &#x3b1;-synuclein. Mol. Med. Rep. 2015;11:1655&#x2013;1660. doi: 10.3892/mmr.2014.3011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2014.3011</ArticleId><ArticleId IdType="pmc">PMC4270325</ArticleId><ArticleId IdType="pubmed">25434876</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster J.M., Darling A.L., Uversky V.N., Blair L.J. Small heat shock proteins, big impact on protein aggregation in neurodegenerative disease. Front. Pharm. 2019;10 doi: 10.3389/fphar.2019.01047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01047</ArticleId><ArticleId IdType="pmc">PMC6759932</ArticleId><ArticleId IdType="pubmed">31619995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogk A., Bukau B. Role of sHsps in organizing cytosolic protein aggregation and disaggregation. Cell Stress Chaperones. 2017;22:493&#x2013;502. doi: 10.1007/s12192-017-0762-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0762-4</ArticleId><ArticleId IdType="pmc">PMC5465027</ArticleId><ArticleId IdType="pubmed">28120291</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 1985;82:4245&#x2013;4249. doi: 10.1073/pnas.82.12.4245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.12.4245</ArticleId><ArticleId IdType="pmc">PMC397973</ArticleId><ArticleId IdType="pubmed">3159021</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean C.A., Cherny R.A., Fraser F.W., Fuller S.J., Smith M.J., Beyreuther K.V., Bush A.I., Masters C.L. Soluble pool of A&#x3b2; amyloid as a determinant of severity of neurodegeneration in Alzheimer&#x2019;s disease. Ann. Neurol. 1999;46:860&#x2013;866. doi: 10.1002/1531-8249(199912)46:6&lt;860::AID-ANA8&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199912)46:6&lt;860::AID-ANA8&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">10589538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue L.-F., Kuo Y.-M., Roher A.E., Brachova L., Shen Y., Sue L., Beach T., Kurth J.H., Rydel R.E., Rogers J. Soluble amyloid &#x3b2; peptide concentration as a predictor of synaptic change in Alzheimer&#x2019;s disease. Am. J. Pathol. 1999;155:853&#x2013;862. doi: 10.1016/S0002-9440(10)65184-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65184-X</ArticleId><ArticleId IdType="pmc">PMC1866907</ArticleId><ArticleId IdType="pubmed">10487842</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535&#x2013;539. doi: 10.1038/416535a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416535a</ArticleId><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadis A. Misregulation of tau alternative splicing in neurodegeneration and dementia. Prog. Mol. Subcell. Biol. 2006;44:89&#x2013;107. doi: 10.1007/978-3-540-34449-0_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-34449-0_5</ArticleId><ArticleId IdType="pubmed">17076266</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A.D.C., Zaidi T., Novak M., Grundke-Iqbal I., Iqbal K. Hyperphosphorylation induces self-assembly of &#x3c4; into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. USA. 2001;98:6923&#x2013;6928. doi: 10.1073/pnas.121119298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.121119298</ArticleId><ArticleId IdType="pmc">PMC34454</ArticleId><ArticleId IdType="pubmed">11381127</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit R., Ross J.L., Goldman Y.E., Holzbaur E.L.F. Differential regulation of dynein and kinesin motor proteins by tau. Science. 2008;319:1086&#x2013;1089. doi: 10.1126/science.1152993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1152993</ArticleId><ArticleId IdType="pmc">PMC2866193</ArticleId><ArticleId IdType="pubmed">18202255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J.-T., Tan L., Hardy J. Apolipoprotein E in Alzheimer&#x2019;s disease: An update. Annu. Rev. Neurosci. 2014;37:79&#x2013;100. doi: 10.1146/annurev-neuro-071013-014300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-071013-014300</ArticleId><ArticleId IdType="pubmed">24821312</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Drouet V., Wu J.W., Witter M.P., Small S.A., Clelland C., Duff K. Trans-synaptic spread of tau pathology in vivo. PLoS ONE. 2012;7:e31302. doi: 10.1371/journal.pone.0031302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031302</ArticleId><ArticleId IdType="pmc">PMC3270029</ArticleId><ArticleId IdType="pubmed">22312444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronner I.F., Ter Meulen B.C., Azmani A., Severijnen L.A., Willemsen R., Kamphorst W., Ravid R., Heutink P., Van Swieten J.C. Hereditary Pick&#x2019;s disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain. 2005;128:2645&#x2013;2653. doi: 10.1093/brain/awh591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh591</ArticleId><ArticleId IdType="pubmed">16014652</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamzadeh F.N. Alpha-synuclein structure, functions, and interactions. J. Res. Med. Sci. 2016;21 doi: 10.4103/1735-1995.181989.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1735-1995.181989</ArticleId><ArticleId IdType="pmc">PMC5122110</ArticleId><ArticleId IdType="pubmed">27904575</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., et al. Mutation in the &#x3b1;-synuclein gene identified in families with Parkinson&#x2019;s disease. Science. 1997;276:2045&#x2013;2047. doi: 10.1126/science.276.5321.2045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.276.5321.2045</ArticleId><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini M.G., Schmidt M.L., Lee V.M.-Y., Trojanowski J.Q., Jakes R., Goedert M. &#x3b1;-synuclein in lewy bodies. Nature. 1997;388:839&#x2013;840. doi: 10.1038/42166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/42166</ArticleId><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Plotkin S.S., Yerbury J.J., Cashman N.R. Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Front. Mol. Neurosci. 2019;12 doi: 10.3389/fnmol.2019.00262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6838634</ArticleId><ArticleId IdType="pubmed">31736708</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Durazo A., Sohn S.H., Strong C.D., Gralla E.B., Whitelegge J.P., Valentine J.S. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl. Acad. Sci. USA. 2008;105:18663&#x2013;18668. doi: 10.1073/pnas.0807058105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807058105</ArticleId><ArticleId IdType="pmc">PMC2585484</ArticleId><ArticleId IdType="pubmed">19022905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Tattum M.H., Jones S., Collinge J., Fisher E.M.C., Jackson G.S. Superoxide dismutase 1 and tgSOD1G93A mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS ONE. 2010;5 doi: 10.1371/journal.pone.0010627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010627</ArticleId><ArticleId IdType="pmc">PMC2869360</ArticleId><ArticleId IdType="pubmed">20498711</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Yerbury J.J., Turner B.J., Guest W.C., Pokrishevsky E., O&#x2019;Neill M.A., Yanai A., Silverman J.M., Zeineddine R., Corcoran L., et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S., Koch M., DeBosier A., McMahon B., Xu G., Borchelt D.R. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadlow W.J. Scrapie and kuru. Lancet. 1959;2:289&#x2013;290. doi: 10.1016/S0140-6736(59)92081-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(59)92081-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G., Scott A., Johnson C., Gunning R., Hancock R., Jeffrey M., Dawson M., Bradley R. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 1987;121:419. doi: 10.1136/vr.121.18.419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/vr.121.18.419</ArticleId><ArticleId IdType="pubmed">3424605</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams E.S., Young S. Spongiform encephalopathy of Rocky Mountain elk. J. Wildl. Dis. 1982;18:465&#x2013;471. doi: 10.7589/0090-3558-18.4.465.</Citation><ArticleIdList><ArticleId IdType="doi">10.7589/0090-3558-18.4.465</ArticleId><ArticleId IdType="pubmed">7154220</ArticleId></ArticleIdList></Reference><Reference><Citation>Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921&#x2013;925. doi: 10.1016/S0140-6736(96)91412-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91412-9</ArticleId><ArticleId IdType="pubmed">8598754</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner S.B., McKinley M.P., Bowman K.A., Bolton D.C., Bendheim P.E., Groth D.F., Glenner G.G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 1983;35:349&#x2013;358. doi: 10.1016/0092-8674(83)90168-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(83)90168-X</ArticleId><ArticleId IdType="pubmed">6418385</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>